Enterprise Value
86.85M
Cash
104.1M
Avg Qtr Burn
-12.23M
Short % of Float
23.36%
Insider Ownership
0.25%
Institutional Own.
96.82%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EO-3021 Details Solid tumor/s, Gastric cancer, Gastroesophageal junction tumors, Cancer | Phase 1 Data readout |